Home  |  Contact

UniProtKB/Swiss-Prot P35499: Variant p.Arg672Gly

Sodium channel protein type 4 subunit alpha
Gene: SCN4A
Variant information

Variant position:  672
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  Disease [Disclaimer]
The variants are classified into three categories: Disease, Polymorphism and Unclassified.
  • Disease: Variants implicated in disease according to literature reports.
  • Polymorphism: Variants not reported to be implicated in disease.
  • Unclassified: Variants with uncertain implication in disease according to literature reports. Evidence against or in favor of a pathogenic role is limited and/or conflicting.

Residue change:  From Arginine (R) to Glycine (G) at position 672 (R672G, p.Arg672Gly).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from large size and basic (R) to glycine (G)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  -2
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Involvement in disease:  Periodic paralysis hypokalemic 2 (HOKPP2) [MIM:613345]: An autosomal dominant disorder manifested by episodic flaccid generalized muscle weakness associated with falls of serum potassium levels. {ECO:0000269|PubMed:10599760, ECO:0000269|PubMed:10851391, ECO:0000269|PubMed:10944223, ECO:0000269|PubMed:11558801, ECO:0000269|PubMed:11591859, ECO:0000269|PubMed:16890191, ECO:0000269|PubMed:17898326, ECO:0000269|PubMed:18162704, ECO:0000269|PubMed:19118277, ECO:0000269|PubMed:20522878, ECO:0000269|PubMed:21043388, ECO:0000269|PubMed:24549961}. Note=The disease is caused by mutations affecting the gene represented in this entry.
The name and a short description of the disease associated with the variant. For more information about the disease, the user can refer to OMIM, following the link provided after the disease acronym.

Variant description:  In HOKPP2.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  672
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  1836
The length of the canonical sequence.

Location on the sequence:   LSLVELGLANVQGLSVLRSF  R LLRVFKLAKSWPTLNMLIKI
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         LSLVELGLANVQGLSVLRSFRLLRVFKLAKSWPTLNMLIKI

Mouse                         LSLVELGLANVQGLSVLRSFRLLRVFKLAKSWPTLNMLIKI

Rat                           LSLVELGLANVQGLSVLRSFRLLRVFKLAKSWPTLNMLIKI

Horse                         LSWVELGLVNVKGLSVLRSFRLVRSLKLAKSWPTLNMFIRI

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 1 – 1836 Sodium channel protein type 4 subunit alpha
Transmembrane 665 – 682 Helical; Name=S4 of repeat II
Repeat 560 – 832 II
Helix 672 – 680


Literature citations

Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current.
Jurkat-Rott K.; Mitrovic N.; Hang C.; Kouzmekine A.; Iaizzo P.; Herzog J.; Lerche H.; Nicole S.; Vale-Santos J.; Chauveau D.; Fontaine B.; Lehmann-Horn F.;
Proc. Natl. Acad. Sci. U.S.A. 97:9549-9554(2000)
Cited for: VARIANTS HOKPP2 GLY-672 AND HIS-672;

The genotype and clinical phenotype of Korean patients with familial hypokalemic periodic paralysis.
Kim J.-B.; Kim M.-H.; Lee S.J.; Kim D.-J.; Lee B.C.;
J. Korean Med. Sci. 22:946-951(2007)
Cited for: VARIANTS HOKPP2 HIS-669; CYS-672 AND GLY-672;

Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis.
Matthews E.; Labrum R.; Sweeney M.G.; Sud R.; Haworth A.; Chinnery P.F.; Meola G.; Schorge S.; Kullmann D.M.; Davis M.B.; Hanna M.G.;
Neurology 72:1544-1547(2009)
Cited for: VARIANTS HOKPP2 TRP-222; CYS-672; GLY-672; HIS-672; SER-672; GLN-1132 AND HIS-1135;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.